<?xml version="1.0" ?>
<!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd">
<pmc-articleset><article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" article-type="case-report">
  <?properties open_access?>
  <front>
    <journal-meta>
      <journal-id journal-id-type="nlm-ta">BMC Res Notes</journal-id>
      <journal-id journal-id-type="iso-abbrev">BMC Res Notes</journal-id>
      <journal-title-group>
        <journal-title>BMC Research Notes</journal-title>
      </journal-title-group>
      <issn pub-type="epub">1756-0500</issn>
      <publisher>
        <publisher-name>BioMed Central</publisher-name>
        <publisher-loc>London</publisher-loc>
      </publisher>
    </journal-meta>
    <article-meta>
      <article-id pub-id-type="pmid">27349224</article-id>
      <article-id pub-id-type="pmc">4924317</article-id>
      <article-id pub-id-type="publisher-id">2132</article-id>
      <article-id pub-id-type="doi">10.1186/s13104-016-2132-1</article-id>
      <article-categories>
        <subj-group subj-group-type="heading">
          <subject>Case Report</subject>
        </subj-group>
      </article-categories>
      <title-group>
        <article-title>Acromegaly in a patient with a pulmonary neuroendocrine tumor: case report and review of current literature</article-title>
      </title-group>
      <contrib-group>
        <contrib contrib-type="author" equal-contrib="yes">
          <name>
            <surname>Krug</surname>
            <given-names>Sebastian</given-names>
          </name>
          <address>
            <email>sebastian.krug@uk-halle.de</email>
          </address>
          <xref ref-type="aff" rid="Aff1"/>
          <xref ref-type="aff" rid="Aff3"/>
        </contrib>
        <contrib contrib-type="author" equal-contrib="yes">
          <name>
            <surname>Boch</surname>
            <given-names>Michael</given-names>
          </name>
          <address>
            <email>Bochm@students.uni-marburg.de</email>
          </address>
          <xref ref-type="aff" rid="Aff1"/>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Rexin</surname>
            <given-names>Peter</given-names>
          </name>
          <address>
            <email>rexin@med.uni-marburg.de</email>
          </address>
          <xref ref-type="aff" rid="Aff2"/>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Pfestroff</surname>
            <given-names>Andreas</given-names>
          </name>
          <address>
            <email>pfestrof@staff.uni-marburg.de</email>
          </address>
          <xref ref-type="aff" rid="Aff4"/>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Gress</surname>
            <given-names>Thomas</given-names>
          </name>
          <address>
            <email>gress@med.uni-marburg.de</email>
          </address>
          <xref ref-type="aff" rid="Aff1"/>
        </contrib>
        <contrib contrib-type="author" corresp="yes">
          <name>
            <surname>Michl</surname>
            <given-names>Patrick</given-names>
          </name>
          <address>
            <email>patrick.michl@uk-halle.de</email>
          </address>
          <xref ref-type="aff" rid="Aff3"/>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Rinke</surname>
            <given-names>Anja</given-names>
          </name>
          <address>
            <email>sprengea@uni-marburg.de</email>
          </address>
          <xref ref-type="aff" rid="Aff1"/>
        </contrib>
        <aff id="Aff1"><label/>Department of Gastroenterology, Endocrinology and Metabolism, Philipps-University Marburg, Marburg, Germany </aff>
        <aff id="Aff2"><label/>Institute of Pathology, Philipps-University Marburg, Marburg, Germany </aff>
        <aff id="Aff3"><label/>Department of Gastroenterology and Hepatology, Martin-Luther University Halle/Wittenberg, Ernst-Grube Stra&#xDF;e 40, 06120 Halle (Saale), Germany </aff>
        <aff id="Aff4"><label/>Department of Nuclear Medicine, University Hospital Marburg, Marburg, Germany </aff>
      </contrib-group>
      <pub-date pub-type="epub">
        <day>27</day>
        <month>6</month>
        <year>2016</year>
      </pub-date>
      <pub-date pub-type="pmc-release">
        <day>27</day>
        <month>6</month>
        <year>2016</year>
      </pub-date>
      <pub-date pub-type="collection">
        <year>2016</year>
      </pub-date>
      <volume>9</volume>
      <elocation-id>326</elocation-id>
      <history>
        <date date-type="received">
          <day>20</day>
          <month>11</month>
          <year>2015</year>
        </date>
        <date date-type="accepted">
          <day>18</day>
          <month>6</month>
          <year>2016</year>
        </date>
      </history>
      <permissions>
        <copyright-statement>&#xA9; The Author(s) 2016</copyright-statement>
        <license license-type="OpenAccess">
          <license-p>
<bold>Open Access</bold>This article is distributed under the terms of the Creative Commons Attribution 4.0 International License (<ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by/4.0/">http://creativecommons.org/licenses/by/4.0/</ext-link>), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (<ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/publicdomain/zero/1.0/">http://creativecommons.org/publicdomain/zero/1.0/</ext-link>) applies to the data made available in this article, unless otherwise stated.</license-p>
        </license>
      </permissions>
      <abstract id="Abs1">
        <sec>
          <title>Background</title>
          <p>Pulmonary neuroendocrine tumors (NET) form a heterogeneous group of rare diseases. In these tumors, paraneoplastic syndromes have been described to drive the course of the disease, among them acromegaly induced by paraneoplastic secretion of growth hormone-releasing hormone (GHRH).</p>
        </sec>
        <sec>
          <title>Case presentation</title>
          <p>We report the case of a 43&#xA0;years old patient initially diagnosed with acromegaly accompanied by weight gain and acral enlargement. Subsequently, further diagnostic work-up identified a solitary pulmonary neuroendocrine tumor (NET). Laboratory tests revealed markedly increased growth hormone (GH) and insulin-like growth factor 1 (IGF-1) without GHRH elevation in the absence of pituitary pathologies confirming the paraneoplastic origin of clinical presentation with acromegaly. Curative surgery was performed leading to normalization of the elevated hormone levels and improvement of the clinical symptoms. Immunohistochemically, a typical carcinoid (TC) was seen with low proliferation index and abundant IGF-1 expression.</p>
        </sec>
        <sec>
          <title>Conclusions</title>
          <p>The association of acromegaly and pulmonary NET has only rarely been reported. We present an individual case of paraneoplastic GH- and IGF-1 secretion in a patient with pulmonary NET. Based on their rarity, the knowledge of paraneoplastic syndromes occurring in patients with pulmonary NET such as acromegaly due to paraneoplastic GH- and IGF-1 secretion is mandatory to adequately diagnose and treat these patients.</p>
        </sec>
      </abstract>
      <kwd-group xml:lang="en">
        <title>Keywords</title>
        <kwd>Paraneoplastic syndromes</kwd>
        <kwd>Acromegaly</kwd>
        <kwd>Pulmonary neuroendocrine tumor</kwd>
        <kwd>GH</kwd>
        <kwd>IGF-1</kwd>
      </kwd-group>
      <custom-meta-group>
        <custom-meta>
          <meta-name>issue-copyright-statement</meta-name>
          <meta-value>&#xA9; The Author(s) 2016</meta-value>
        </custom-meta>
      </custom-meta-group>
    </article-meta>
  </front>
  <body>
    <sec id="Sec1">
      <title>Background</title>
      <p>Pulmonary neuroendocrine tumors (NET) represent rare malignancies with an incidence between 0.2 and 2.0/100.000 inhabitants [<xref ref-type="bibr" rid="CR1">1</xref>]. The incidence is increasing over the last decades which probably reflects increased awareness of this entity. The literature describes up to 25&#xA0;% of all neuroendocrine neoplasias (NEN) and approximately 2&#xA0;% of all lung tumors as pulmonary NET [<xref ref-type="bibr" rid="CR2">2</xref>&#x2013;<xref ref-type="bibr" rid="CR4">4</xref>]. Only few pulmonary NET (5&#xA0;%) are associated with multiple endocrine neoplasia type 1 (MEN-1) syndrome [<xref ref-type="bibr" rid="CR5">5</xref>]. Pulmonary NET can be classified into typical carcinoids (TC) and atypical carcinoids (AC) based on clinico-pathological features [<xref ref-type="bibr" rid="CR4">4</xref>]. TC are 5&#x2013;10 times more frequently compared to AC. Up to 15&#xA0;% of TC have already metastasized at time of presentation [<xref ref-type="bibr" rid="CR6">6</xref>]. Histopathological assessment comprises mitotic-index and necrosis to differ between both subtypes [<xref ref-type="bibr" rid="CR7">7</xref>]. Moreover, pulmonary NET have been linked to hormone syndromes in up to 30&#xA0;% of the cases which include carcinoid-, cushing- and inappropriate antidiuretic hormone secretion syndrome as well as rarely acromegaly [<xref ref-type="bibr" rid="CR4">4</xref>, <xref ref-type="bibr" rid="CR8">8</xref>]. Less than 1&#xA0;% of all acromegaly cases are caused by non-pituitary tumors. In these cases, usually growth hormone (GH) is hypersecreted [<xref ref-type="bibr" rid="CR9">9</xref>]. This report presents a patient with acromegaly due to rare paraneoplastic GH and IGF-1 secretion mediated by a pulmonary NET.</p>
    </sec>
    <sec id="Sec2">
      <title>Case report</title>
      <p>Three years before presenting at our ENETS center, when he was 43&#xA0;years old, the patient was diagnosed with a WHO grade 1 subependymoma. This intracranial lesion was resected microsurgically in an external hospital. Further pre-existing conditions were unknown. After surgery the patient complained about dyspnea and cough. An X-ray examination at that time revealed a right-sided basal pneumonia, which was treated with antibiotics. However, during the following years, the patient suffered from an abnormal feeling of satiety, weight gain of 20&#xA0;kg in 3&#xA0;years and acral enlargement (Fig.&#xA0;<xref rid="Fig1" ref-type="fig">1</xref>). His shoe size increased from 44 to 46, the size of gloves from 9 to 11. Furthermore, he developed pain in his ankles, knees as well as in his hips and femur. He noticed a protrusion of the jaw and a clipped speech due to macroglossia and sleeping apnea. Repeated contrast-enhanced imaging studies were performed to rule out pathologies at the level of the pituitary gland. These examinations did not reveal any evidence of a pituitary adenoma. However, growth hormone (GH) and insulin-like growth factor 1 (IGF-1) levels were found to be massively elevated (Table&#xA0;<xref rid="Tab1" ref-type="table">1</xref>). In contrast, growth hormone-releasing hormone (GHRH) was not elevated. GH suppression testing showed clearly the presence of a clinically active acromegaly. A subsequent <sup>68</sup>Gallium-DOTATOC PET-CT revealed a large tumor-atelectasis-complex in the right basal upper lobe with a compression of the middle and lower bronchus with somatostatin receptor positivity indicative for a well-differentiated neuroendocrine pulmonary tumor (Fig. <xref rid="Fig2" ref-type="fig">2</xref>). Retrospectively, a tumor formation could be assumed when comparing X-ray images of 2010 with actual PET-CT. Metastatic lesions were not detected by PET-CT indicating a localized disease stage. Subsequently, endobronchial ultrasound with transbronchial needle aspiration was performed. The tissue was analyzed immunohistochemically revealing an intense positive staining for synaptophysin, chromogranin A and CD 56 with a small amount of Ki-67 positive cells (Fig. <xref rid="Fig3" ref-type="fig">3</xref>). In contrast, TTF-1 was negative. Following interdisciplinary tumor board recommendation, the patient has been resected in curative intent and lobectomy was performed. Afterwards, immunohistochemical evaluations presented a typical pulmonary carcinoid (Ki-67&#xA0;&lt;&#xA0;2&#xA0;%) with abundant IGF-1 expression as cause of the acromegaly (Figs. <xref rid="Fig3" ref-type="fig">3</xref> and <xref rid="Fig4" ref-type="fig">4</xref>). Postoperative blood tests confirmed the normalization of circulating GH and IGF-1 as markers of complete removal of the tumor (Table <xref rid="Tab1" ref-type="table">1</xref>). Clinically, the patient improved dramatically. Analysis of the coding region of the MEN 1-gen (Exon 2&#x2013;10; Chromosome 11q13) and flanking intron regions did not reveal any aberration of the sequence or deletion/duplication of single exons. Moreover, also the family history of the patient did not present the diagnosis of a neuroendocrine neoplasia. To date, the patient is recurrence-free and under follow-up.<fig id="Fig1"><label>Fig.&#xA0;1</label><caption><p>Representative image of the patient&#x2019;s hand (<italic>left side</italic>) before surgery compared to a hand of one of our doctors</p></caption><graphic xlink:href="13104_2016_2132_Fig1_HTML" id="MO1"/></fig><table-wrap id="Tab1"><label>Table&#xA0;1</label><caption><p>Pre- and post-surgery biomarkers for acromegaly</p></caption><table frame="hsides" rules="groups"><thead><tr><th align="left"/><th align="left">Standard</th><th align="left">Pre-surgery 03/2014</th><th align="left">Post-surgery 09/2014</th></tr></thead><tbody><tr><td align="left">GH in ng/ml</td><td align="left">&lt;0.8</td><td align="left">10.2</td><td align="left">0.3</td></tr><tr><td align="left">IGF-1 in &#xB5;m/l</td><td align="left">101&#x2013;267</td><td align="left">1294</td><td align="left">261</td></tr><tr><td align="left">CgA in U/l</td><td align="left">&lt;18</td><td align="left">164</td><td align="left">31</td></tr><tr><td align="left">HbA1c in &#xA0;%</td><td align="left">&lt;6</td><td align="left">6.8</td><td align="left">6.0</td></tr></tbody></table></table-wrap><fig id="Fig2"><label>Fig.&#xA0;2</label><caption><p>
<sup>68</sup>Gallium-DOTATOC PET-CT before surgery revealed a large tumor mass located in the <italic>right</italic> lung with high somatostatin receptor expression. Isolated CT- and PET component (<bold>a</bold>
<italic>left side</italic> and <bold>b</bold>) is presented as well as combined images (<bold>a</bold>
<italic>right side</italic>). Metastatic spread was excluded as seen on the planar reconstruction (<bold>b</bold>
<italic>right side</italic>)</p></caption><graphic xlink:href="13104_2016_2132_Fig2_HTML" id="MO2"/></fig><fig id="Fig3"><label>Fig.&#xA0;3</label><caption><p>Neuroendocrine tumor with typical growth pattern. Tumor cells show intermediate cytological pleomorphy and a distinct &#x2018;&#x2018;pepper and salt&#x2019;&#x2019; chromatin of the nucleolus as well as details of the so called &#x201C;Zellballen&#x201D; or nesting pattern (<bold>a</bold>). Antibodies directed against chromogranin <bold>a</bold> show a strong staining pattern (<bold>b</bold>) while synaptophysin is intermediately expressed (<bold>c</bold>). Immunohiostochemical staining with antibodies against Ki-67 indicate a low proliferation rate &lt;2&#xA0;% (<bold>d</bold>)</p></caption><graphic xlink:href="13104_2016_2132_Fig3_HTML" id="MO3"/></fig><fig id="Fig4"><label>Fig.&#xA0;4</label><caption><p>Abundant cytoplasmic protein expression of IGF-1 in the resected tumor specimen as detected by immunohistochemistry</p></caption><graphic xlink:href="13104_2016_2132_Fig4_HTML" id="MO4"/></fig></p>
    </sec>
    <sec id="Sec3">
      <title>Discussion</title>
      <sec id="Sec4">
        <title>Pulmonary neuroendocrine tumors</title>
        <p>Up to 2&#xA0;% of all lung cancers are pulmonary neuroendocrine tumors [<xref ref-type="bibr" rid="CR2">2</xref>, <xref ref-type="bibr" rid="CR4">4</xref>, <xref ref-type="bibr" rid="CR10">10</xref>]. 25&#xA0;% of all neuroendocrine tumors are located in the respiratory tract what makes them the most frequent extraintestinal site for NET [<xref ref-type="bibr" rid="CR11">11</xref>]. The reported annual incidence of pulmonary NET equals about 1.35/100,000 [<xref ref-type="bibr" rid="CR12">12</xref>]. These malignancies form a heterogeneous subset of neoplasias including typical (TC) and atypical carcinoid (AC) tumors, large cell neuroendocrine carcinoma (LCLC) and the most frequently occurring small cell lung cancer (SCLC) which is mostly considered as separate entity. Poorly differentiated neuroendocrine carcinomas display a highly distinct phenotype compared to pulmonary NET in terms of prevalence, biology and prognosis. The following discussion will focus on the typical and atypical carcinoid tumors, since poorly differentiated neuroendocrine carcinomas are characterized by a grossly different biological behavior and are associated with a poor prognosis. Pulmonary NET frequently develop in the bronchial system. Therefore, they likely cause coughing, wheezing, hemoptysis and recurrent pneumonia [<xref ref-type="bibr" rid="CR13">13</xref>]. If metastasized, typical have a considerably better prognosis compared to atypical NET (15 vs. 50&#xA0;% risk of metastatic disease by first presentation). According to prior published series, 5- and 10-year survival rates are 80&#xA0;% for TC (both time points) and 50 and 35&#xA0;% for AC stage [<xref ref-type="bibr" rid="CR1">1</xref>, <xref ref-type="bibr" rid="CR14">14</xref>].</p>
      </sec>
      <sec id="Sec5">
        <title>Paraneoplastic endocrine syndromes (ectopic hormone production)</title>
        <p>Paraneoplastic endocrine syndromes (PES) are caused by tumors capable of producing a variety of functionally active peptides that imitate hormone function and lead to a metabolic disturbance [<xref ref-type="bibr" rid="CR15">15</xref>]. Tumors derived from tissues that normally do not produce hormones lead to &#x201C;ectopic&#x201D; or &#x201C;inappropriate&#x201D; hormone production [<xref ref-type="bibr" rid="CR16">16</xref>]. Neoplastic dedifferentiation can possibly activate repressed genes. That is the reason why this phenomenon most frequently arises in dedifferentiated tumors such as small cell lung cancer [<xref ref-type="bibr" rid="CR17">17</xref>]. Commonly occurring PES are ACTH or CRH production leading to cushing syndrome, hypercalcemia caused by parathyroid hormone-related protein or syndrome of inappropriate secretion of antidiuretic hormone (SIADH).</p>
        <p>In our case the patient presented with the rare paraneoplastic manifestation of acromegaly. Acromegaly represents a rare condition usually affecting middle-aged adults with a prevalence of 40&#x2013;70 cases per million and an incidence rate of 3&#x2013;4 cases per million per year [<xref ref-type="bibr" rid="CR18">18</xref>&#x2013;<xref ref-type="bibr" rid="CR21">21</xref>]. This disease mostly results from persistent hypersecretion of growth hormone (GH) leading to hepatic overproduction of insulin-like growth factor-1 (IGF-1). However, both hypersecretion of growth hormone-releasing hormone (GHRH) and growth hormone (GH) may lead to acromegaly. These hormones are produced by the pituitary gland or non-pituitary tumors rarely occur in association with familial syndromes. The vast majority of about 90&#xA0;% of the patients with acromegaly have a benign pituitary adenoma with monoclonal GH secretion whereof 70&#xA0;% are macroadenomas (&gt;1&#xA0;cm) at diagnosis [<xref ref-type="bibr" rid="CR22">22</xref>, <xref ref-type="bibr" rid="CR23">23</xref>]. Ectopic secretion of GH has only been described in single cases [<xref ref-type="bibr" rid="CR24">24</xref>, <xref ref-type="bibr" rid="CR25">25</xref>]. Non-pituitary tumors such as small-cell lung cancer, adrenal adenoma, medullary thyroid carcinoma or pheochromocytoma or pancreatic neuroendocrine tumors can lead to acromegaly by production of growth hormone&#x2013;releasing hormone (GHRH) [<xref ref-type="bibr" rid="CR26">26</xref>]. Peripheral production of GHRH causes hyperstimulation of somatotroph cells with subsequently increased GH secretion and hepatic IGF-1 release. Ectopic acromegaly represents less than 1&#xA0;% of the reported cases of acromegaly [<xref ref-type="bibr" rid="CR27">27</xref>]. The most common signs are&#x2014;as the name suggests&#x2014;acral and soft tissue overgrowth and the typical coarse facies. Acral enlargement is typically noticed by tightness of rings or an increasing shoe size. As physical changes occur gradually clinical diagnosis is often delayed. If acromegaly is suspected IGF-1 measurement and a GH suppression test will be performed. Imaging helps to pinpoint the location and the size of a suspected tumor. Cardiac and respiratory disorders along with arthropathy rank amongst the most frequent systemic complication that lead to increased morbidity and mortality [<xref ref-type="bibr" rid="CR28">28</xref>, <xref ref-type="bibr" rid="CR29">29</xref>]. Patients benefit extensively from controlling GH and IGF-1 hypersecretion either surgically or by pharmacotherapy [<xref ref-type="bibr" rid="CR30">30</xref>]. This can effectively be achieved by somatostatin. Long acting somatostatin analogs may control ectopic hormonal secretion syndrome, and restrict tumor growth [<xref ref-type="bibr" rid="CR31">31</xref>].</p>
        <p>Single cases of neuroendocrine tumors causing acromegaly have been described with tumors deriving from duodenum [<xref ref-type="bibr" rid="CR32">32</xref>], liver [<xref ref-type="bibr" rid="CR33">33</xref>] and from the pancreas in the context of multiple endocrine neoplasia type 1 [<xref ref-type="bibr" rid="CR9">9</xref>, <xref ref-type="bibr" rid="CR34">34</xref>, <xref ref-type="bibr" rid="CR35">35</xref>]. In addition, acromegaly due to GHRH hypersecretion in carcinoid tumors is the most common cause [<xref ref-type="bibr" rid="CR27">27</xref>, <xref ref-type="bibr" rid="CR36">36</xref>, <xref ref-type="bibr" rid="CR37">37</xref>], whereas paraneoplastic GH secretion is extremely rare in NET [<xref ref-type="bibr" rid="CR24">24</xref>].</p>
        <p>In summary, the case presented here is an extremely rare example of a sporadic pulmonary NET associated with GH and IGF-1 but not GHRH secretion, thereby inducing a clinically florid acromegaly. Thus, mostly inapparent pulmonary NET induce relevant symptoms which should accurately be clarified.</p>
      </sec>
    </sec>
    <sec id="Sec6">
      <title>Methods</title>
      <p>We retrospectively analyzed a patient with a pulmonary NET treated and followed-up in our institution since 2013. This case presentation was conducted in accordance with the Declaration of Helsinki. Tumor tissue was explored immunohistochemically concerning expression of chromogranin A, synaptophysin and Ki-67. Analyses were performed according to a standardized protocol using Leica-Bond-Max-Autostainer and the antibodies in the following dilutions: Chromogranin: Dako 1:400; Synaptophysin: Dako 1:400; Ki-67: Dako 1:1000. For IGF-1 we used the ABCM ab 40,657 in the following dilution: 1:400.</p>
      <p>The CARE guidelines were followed in accordance with the journal policies.</p>
    </sec>
  </body>
  <back>
    <glossary>
      <title>Abbreviations</title>
      <def-list>
        <def-item>
          <term>NET</term>
          <def>
            <p>neuroendocrine tumor</p>
          </def>
        </def-item>
        <def-item>
          <term>NEN</term>
          <def>
            <p>neuroendocrine neoplasia</p>
          </def>
        </def-item>
        <def-item>
          <term>GH</term>
          <def>
            <p>growth hormone</p>
          </def>
        </def-item>
        <def-item>
          <term>GHRH</term>
          <def>
            <p>growth hormone-releasing hormone</p>
          </def>
        </def-item>
        <def-item>
          <term>IGF-1</term>
          <def>
            <p>insulin-like growth factor 1</p>
          </def>
        </def-item>
        <def-item>
          <term>TC</term>
          <def>
            <p>typical carcinoid</p>
          </def>
        </def-item>
        <def-item>
          <term>AT</term>
          <def>
            <p>atypical carcinoid</p>
          </def>
        </def-item>
        <def-item>
          <term>LCLC</term>
          <def>
            <p>large cell neuroendocrine carcinoma</p>
          </def>
        </def-item>
        <def-item>
          <term>SCLC</term>
          <def>
            <p>small cell lung cancer</p>
          </def>
        </def-item>
        <def-item>
          <term>PES</term>
          <def>
            <p>paraneoplastic endocrine syndromes</p>
          </def>
        </def-item>
        <def-item>
          <term>CgA</term>
          <def>
            <p>chromogranin A</p>
          </def>
        </def-item>
      </def-list>
    </glossary>
    <fn-group>
      <fn>
        <p>Sebastian Krug and Michael Boch contributed equally to this work</p>
      </fn>
    </fn-group>
    <ack>
      <title>Authors&#x2019; contributions</title>
      <p>PR carried out the immunohistochemical assessments. AR, MB and SK carried out the clinical management of the patient. AP evaluated the PET-CT images. MB, SK, TMG, PM and AR designed and revised the manuscript. All authors read and approved the final manuscript.</p>
      <sec id="FPar1">
        <title>Acknowledgements</title>
        <p>We gratefully acknowledge the patient for collaboration and the pathologist Dr. Mlynek-Kersjes for providing tumor tissue.</p>
      </sec>
      <sec id="FPar2">
        <title>Competing interests</title>
        <p>The authors declare that they have no competing interests.</p>
      </sec>
      <sec id="FPar3">
        <title>Availability of data and materials</title>
        <p>All information are included within the article.</p>
      </sec>
      <sec id="FPar4">
        <title>Consent for publication</title>
        <p>Written informed consent wa s obtained from the patient for publication and the accompanying images.</p>
      </sec>
      <sec id="FPar5">
        <title>Ethical approval and consent to participate</title>
        <p>Not applicable.</p>
      </sec>
      <sec id="FPar6">
        <title>Funding</title>
        <p>Not applicable.</p>
      </sec>
    </ack>
    <ref-list id="Bib1">
      <title>References</title>
      <ref id="CR1">
        <label>1.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Yao</surname>
              <given-names>JC</given-names>
            </name>
            <name>
              <surname>Hassan</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Phan</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Dagohoy</surname>
              <given-names>C</given-names>
            </name>
            <name>
              <surname>Leary</surname>
              <given-names>C</given-names>
            </name>
            <name>
              <surname>Mares</surname>
              <given-names>JE</given-names>
            </name>
            <name>
              <surname>Abdalla</surname>
              <given-names>EK</given-names>
            </name>
            <name>
              <surname>Fleming</surname>
              <given-names>JB</given-names>
            </name>
            <name>
              <surname>Vauthey</surname>
              <given-names>JN</given-names>
            </name>
            <name>
              <surname>Rashid</surname>
              <given-names>A</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>One hundred years after carcinoid: epidemiology of and prognostic factors for neuroendocrine tumors in 35,825 cases in the United States</article-title>
          <source>J Clin Oncol</source>
          <year>2008</year>
          <volume>26</volume>
          <issue>18</issue>
          <fpage>3063</fpage>
          <lpage>3072</lpage>
          <pub-id pub-id-type="doi">10.1200/JCO.2007.15.4377</pub-id>
          <pub-id pub-id-type="pmid">18565894</pub-id>
        </element-citation>
      </ref>
      <ref id="CR2">
        <label>2.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Naalsund</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Rostad</surname>
              <given-names>H</given-names>
            </name>
            <name>
              <surname>Str&#xF8;m</surname>
              <given-names>EH</given-names>
            </name>
            <name>
              <surname>Lund</surname>
              <given-names>MB</given-names>
            </name>
            <name>
              <surname>Strand</surname>
              <given-names>TE</given-names>
            </name>
          </person-group>
          <article-title>Carcinoid lung tumors&#x2013;incidence, treatment and outcomes: a population-based study</article-title>
          <source>Eur J Cardiothorac Surg</source>
          <year>2011</year>
          <volume>39</volume>
          <issue>4</issue>
          <fpage>565</fpage>
          <lpage>569</lpage>
          <pub-id pub-id-type="doi">10.1016/j.ejcts.2010.08.036</pub-id>
          <pub-id pub-id-type="pmid">20888248</pub-id>
        </element-citation>
      </ref>
      <ref id="CR3">
        <label>3.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>H&#xF6;rsch</surname>
              <given-names>D</given-names>
            </name>
            <name>
              <surname>Schmid</surname>
              <given-names>KW</given-names>
            </name>
            <name>
              <surname>Anlauf</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Darwiche</surname>
              <given-names>K</given-names>
            </name>
            <name>
              <surname>Denecke</surname>
              <given-names>T</given-names>
            </name>
            <name>
              <surname>Baum</surname>
              <given-names>RP</given-names>
            </name>
            <name>
              <surname>Spitzweg</surname>
              <given-names>C</given-names>
            </name>
            <name>
              <surname>Groh&#xE9;</surname>
              <given-names>C</given-names>
            </name>
            <name>
              <surname>Presselt</surname>
              <given-names>N</given-names>
            </name>
            <name>
              <surname>Stremmel</surname>
              <given-names>C</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Neuroendocrine tumors of the bronchopulmonary system (typical and atypical carcinoid tumors): current strategies in diagnosis and treatment. Conclusions of an expert meeting February 2011 in Weimar, Germany</article-title>
          <source>Oncol Res Treat</source>
          <year>2014</year>
          <volume>37</volume>
          <issue>5</issue>
          <fpage>266</fpage>
          <lpage>276</lpage>
          <pub-id pub-id-type="doi">10.1159/000362430</pub-id>
          <pub-id pub-id-type="pmid">24853787</pub-id>
        </element-citation>
      </ref>
      <ref id="CR4">
        <label>4.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Caplin</surname>
              <given-names>ME</given-names>
            </name>
            <name>
              <surname>Baudin</surname>
              <given-names>E</given-names>
            </name>
            <name>
              <surname>Ferolla</surname>
              <given-names>P</given-names>
            </name>
            <name>
              <surname>Filosso</surname>
              <given-names>P</given-names>
            </name>
            <name>
              <surname>Garcia-Yuste</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Lim</surname>
              <given-names>E</given-names>
            </name>
            <name>
              <surname>Oberg</surname>
              <given-names>K</given-names>
            </name>
            <name>
              <surname>Pelosi</surname>
              <given-names>G</given-names>
            </name>
            <name>
              <surname>Perren</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Rossi</surname>
              <given-names>RE</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Pulmonary neuroendocrine (carcinoid) tumors: european Neuroendocrine Tumor Society expert consensus and recommendations for best practice for typical and atypical pulmonary carcinoids</article-title>
          <source>Ann Oncol</source>
          <year>2015</year>
          <volume>26</volume>
          <issue>8</issue>
          <fpage>1604</fpage>
          <lpage>1620</lpage>
          <pub-id pub-id-type="doi">10.1093/annonc/mdv041</pub-id>
          <pub-id pub-id-type="pmid">25646366</pub-id>
        </element-citation>
      </ref>
      <ref id="CR5">
        <label>5.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Oliveira</surname>
              <given-names>AM</given-names>
            </name>
            <name>
              <surname>Tazelaar</surname>
              <given-names>HD</given-names>
            </name>
            <name>
              <surname>Wentzlaff</surname>
              <given-names>KA</given-names>
            </name>
            <name>
              <surname>Kosugi</surname>
              <given-names>NS</given-names>
            </name>
            <name>
              <surname>Hai</surname>
              <given-names>N</given-names>
            </name>
            <name>
              <surname>Benson</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Miller</surname>
              <given-names>DL</given-names>
            </name>
            <name>
              <surname>Yang</surname>
              <given-names>P</given-names>
            </name>
          </person-group>
          <article-title>Familial pulmonary carcinoid tumors</article-title>
          <source>Cancer</source>
          <year>2001</year>
          <volume>91</volume>
          <issue>11</issue>
          <fpage>2104</fpage>
          <lpage>2109</lpage>
          <pub-id pub-id-type="doi">10.1002/1097-0142(20010601)91:11&lt;2104::AID-CNCR1238&gt;3.0.CO;2-I</pub-id>
          <pub-id pub-id-type="pmid">11391591</pub-id>
        </element-citation>
      </ref>
      <ref id="CR6">
        <label>6.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Lou</surname>
              <given-names>F</given-names>
            </name>
            <name>
              <surname>Sarkaria</surname>
              <given-names>I</given-names>
            </name>
            <name>
              <surname>Pietanza</surname>
              <given-names>C</given-names>
            </name>
            <name>
              <surname>Travis</surname>
              <given-names>W</given-names>
            </name>
            <name>
              <surname>Roh</surname>
              <given-names>MS</given-names>
            </name>
            <name>
              <surname>Sica</surname>
              <given-names>G</given-names>
            </name>
            <name>
              <surname>Healy</surname>
              <given-names>D</given-names>
            </name>
            <name>
              <surname>Rusch</surname>
              <given-names>V</given-names>
            </name>
            <name>
              <surname>Huang</surname>
              <given-names>J</given-names>
            </name>
          </person-group>
          <article-title>Recurrence of pulmonary carcinoid tumors after resection: implications for postoperative surveillance</article-title>
          <source>Ann Thorac Surg</source>
          <year>2013</year>
          <volume>96</volume>
          <issue>4</issue>
          <fpage>1156</fpage>
          <lpage>1162</lpage>
          <pub-id pub-id-type="doi">10.1016/j.athoracsur.2013.05.047</pub-id>
          <pub-id pub-id-type="pmid">23915584</pub-id>
        </element-citation>
      </ref>
      <ref id="CR7">
        <label>7.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Travis</surname>
              <given-names>WD</given-names>
            </name>
            <name>
              <surname>Gal</surname>
              <given-names>AA</given-names>
            </name>
            <name>
              <surname>Colby</surname>
              <given-names>TV</given-names>
            </name>
            <name>
              <surname>Klimstra</surname>
              <given-names>DS</given-names>
            </name>
            <name>
              <surname>Falk</surname>
              <given-names>R</given-names>
            </name>
            <name>
              <surname>Koss</surname>
              <given-names>MN</given-names>
            </name>
          </person-group>
          <article-title>Reproducibility of neuroendocrine lung tumor classification</article-title>
          <source>Hum Pathol</source>
          <year>1998</year>
          <volume>29</volume>
          <issue>3</issue>
          <fpage>272</fpage>
          <lpage>279</lpage>
          <pub-id pub-id-type="doi">10.1016/S0046-8177(98)90047-8</pub-id>
          <pub-id pub-id-type="pmid">9496831</pub-id>
        </element-citation>
      </ref>
      <ref id="CR8">
        <label>8.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Kaltsas</surname>
              <given-names>G</given-names>
            </name>
            <name>
              <surname>Androulakis</surname>
              <given-names>II</given-names>
            </name>
            <name>
              <surname>de Herder</surname>
              <given-names>WW</given-names>
            </name>
            <name>
              <surname>Grossman</surname>
              <given-names>AB</given-names>
            </name>
          </person-group>
          <article-title>Paraneoplastic syndromes secondary to neuroendocrine tumours</article-title>
          <source>Endocr Relat Cancer</source>
          <year>2010</year>
          <volume>17</volume>
          <issue>3</issue>
          <fpage>R173</fpage>
          <lpage>R193</lpage>
          <pub-id pub-id-type="doi">10.1677/ERC-10-0024</pub-id>
          <pub-id pub-id-type="pmid">20530594</pub-id>
        </element-citation>
      </ref>
      <ref id="CR9">
        <label>9.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Biermasz</surname>
              <given-names>NR</given-names>
            </name>
            <name>
              <surname>Smit</surname>
              <given-names>JW</given-names>
            </name>
            <name>
              <surname>Pereira</surname>
              <given-names>AM</given-names>
            </name>
            <name>
              <surname>Fr&#xF6;lich</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Romijn</surname>
              <given-names>JA</given-names>
            </name>
            <name>
              <surname>Roelfsema</surname>
              <given-names>F</given-names>
            </name>
          </person-group>
          <article-title>Acromegaly caused by growth hormone-releasing hormone-producing tumors: long-term observational studies in three patients</article-title>
          <source>Pituitary</source>
          <year>2007</year>
          <volume>10</volume>
          <issue>3</issue>
          <fpage>237</fpage>
          <lpage>249</lpage>
          <pub-id pub-id-type="doi">10.1007/s11102-007-0045-7</pub-id>
          <pub-id pub-id-type="pmid">17541749</pub-id>
        </element-citation>
      </ref>
      <ref id="CR10">
        <label>10.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Chen</surname>
              <given-names>LC</given-names>
            </name>
            <name>
              <surname>Travis</surname>
              <given-names>WD</given-names>
            </name>
            <name>
              <surname>Krug</surname>
              <given-names>LM</given-names>
            </name>
          </person-group>
          <article-title>Pulmonary neuroendocrine tumors: what (little) do we know?</article-title>
          <source>J Natl Compr Canc Netw</source>
          <year>2006</year>
          <volume>4</volume>
          <issue>6</issue>
          <fpage>623</fpage>
          <lpage>630</lpage>
          <pub-id pub-id-type="pmid">16813729</pub-id>
        </element-citation>
      </ref>
      <ref id="CR11">
        <label>11.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <collab>&#xD6;berg K, Hellman P, Ferolla P, Papotti M, Group EGW</collab>
          </person-group>
          <article-title>Neuroendocrine bronchial and thymic tumors: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up</article-title>
          <source>Ann Oncol</source>
          <year>2012</year>
          <volume>23</volume>
          <issue>Suppl 7</issue>
          <fpage>vii120</fpage>
          <lpage>123</lpage>
          <pub-id pub-id-type="pmid">22997444</pub-id>
        </element-citation>
      </ref>
      <ref id="CR12">
        <label>12.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Modlin</surname>
              <given-names>IM</given-names>
            </name>
            <name>
              <surname>Lye</surname>
              <given-names>KD</given-names>
            </name>
            <name>
              <surname>Kidd</surname>
              <given-names>M</given-names>
            </name>
          </person-group>
          <article-title>A 5-decade analysis of 13,715 carcinoid tumors</article-title>
          <source>Cancer</source>
          <year>2003</year>
          <volume>97</volume>
          <issue>4</issue>
          <fpage>934</fpage>
          <lpage>959</lpage>
          <pub-id pub-id-type="doi">10.1002/cncr.11105</pub-id>
          <pub-id pub-id-type="pmid">12569593</pub-id>
        </element-citation>
      </ref>
      <ref id="CR13">
        <label>13.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Kulke</surname>
              <given-names>MH</given-names>
            </name>
          </person-group>
          <article-title>Clinical presentation and management of carcinoid tumors</article-title>
          <source>Hematol Oncol Clin North Am</source>
          <year>2007</year>
          <volume>21</volume>
          <issue>3</issue>
          <fpage>433</fpage>
          <lpage>455; vii-viii</lpage>
          <pub-id pub-id-type="doi">10.1016/j.hoc.2007.04.004</pub-id>
          <pub-id pub-id-type="pmid">17548033</pub-id>
        </element-citation>
      </ref>
      <ref id="CR14">
        <label>14.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Travis</surname>
              <given-names>WD</given-names>
            </name>
            <name>
              <surname>Rush</surname>
              <given-names>W</given-names>
            </name>
            <name>
              <surname>Flieder</surname>
              <given-names>DB</given-names>
            </name>
            <name>
              <surname>Falk</surname>
              <given-names>R</given-names>
            </name>
            <name>
              <surname>Fleming</surname>
              <given-names>MV</given-names>
            </name>
            <name>
              <surname>Gal</surname>
              <given-names>AA</given-names>
            </name>
            <name>
              <surname>Koss</surname>
              <given-names>MN</given-names>
            </name>
          </person-group>
          <article-title>Survival analysis of 200 pulmonary neuroendocrine tumors with clarification of criteria for atypical carcinoid and its separation from typical carcinoid</article-title>
          <source>Am J Surg Pathol</source>
          <year>1998</year>
          <volume>22</volume>
          <issue>8</issue>
          <fpage>934</fpage>
          <lpage>944</lpage>
          <pub-id pub-id-type="doi">10.1097/00000478-199808000-00003</pub-id>
          <pub-id pub-id-type="pmid">9706973</pub-id>
        </element-citation>
      </ref>
      <ref id="CR15">
        <label>15.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>DeLellis</surname>
              <given-names>RA</given-names>
            </name>
            <name>
              <surname>Xia</surname>
              <given-names>L</given-names>
            </name>
          </person-group>
          <article-title>Paraneoplastic endocrine syndromes: a review</article-title>
          <source>Endocr Pathol</source>
          <year>2003</year>
          <volume>14</volume>
          <issue>4</issue>
          <fpage>303</fpage>
          <lpage>317</lpage>
          <pub-id pub-id-type="doi">10.1385/EP:14:4:303</pub-id>
          <pub-id pub-id-type="pmid">14739488</pub-id>
        </element-citation>
      </ref>
      <ref id="CR16">
        <label>16.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Baylin</surname>
              <given-names>SB</given-names>
            </name>
            <name>
              <surname>Mendelsohn</surname>
              <given-names>G</given-names>
            </name>
          </person-group>
          <article-title>Ectopic (inappropriate) hormone production by tumors: mechanisms involved and the biological and clinical implications</article-title>
          <source>Endocr Rev</source>
          <year>1980</year>
          <volume>1</volume>
          <issue>1</issue>
          <fpage>45</fpage>
          <lpage>77</lpage>
          <pub-id pub-id-type="doi">10.1210/edrv-1-1-45</pub-id>
          <pub-id pub-id-type="pmid">6164550</pub-id>
        </element-citation>
      </ref>
      <ref id="CR17">
        <label>17.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Gandhi</surname>
              <given-names>L</given-names>
            </name>
            <name>
              <surname>Johnson</surname>
              <given-names>BE</given-names>
            </name>
          </person-group>
          <article-title>Paraneoplastic syndromes associated with small cell lung cancer</article-title>
          <source>J Natl Compr Canc Netw</source>
          <year>2006</year>
          <volume>4</volume>
          <issue>6</issue>
          <fpage>631</fpage>
          <lpage>638</lpage>
          <pub-id pub-id-type="pmid">16813730</pub-id>
        </element-citation>
      </ref>
      <ref id="CR18">
        <label>18.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Holdaway</surname>
              <given-names>IM</given-names>
            </name>
            <name>
              <surname>Rajasoorya</surname>
              <given-names>C</given-names>
            </name>
          </person-group>
          <article-title>Epidemiology of acromegaly</article-title>
          <source>Pituitary</source>
          <year>1999</year>
          <volume>2</volume>
          <issue>1</issue>
          <fpage>29</fpage>
          <lpage>41</lpage>
          <pub-id pub-id-type="doi">10.1023/A:1009965803750</pub-id>
          <pub-id pub-id-type="pmid">11081170</pub-id>
        </element-citation>
      </ref>
      <ref id="CR19">
        <label>19.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Bengtsson</surname>
              <given-names>BA</given-names>
            </name>
            <name>
              <surname>Ed&#xE9;n</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Ernest</surname>
              <given-names>I</given-names>
            </name>
            <name>
              <surname>Od&#xE9;n</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Sj&#xF6;gren</surname>
              <given-names>B</given-names>
            </name>
          </person-group>
          <article-title>Epidemiology and long-term survival in acromegaly. A study of 166 cases diagnosed between 1955 and 1984</article-title>
          <source>Acta Med Scand</source>
          <year>1988</year>
          <volume>223</volume>
          <issue>4</issue>
          <fpage>327</fpage>
          <lpage>335</lpage>
          <pub-id pub-id-type="doi">10.1111/j.0954-6820.1988.tb15881.x</pub-id>
          <pub-id pub-id-type="pmid">3369313</pub-id>
        </element-citation>
      </ref>
      <ref id="CR20">
        <label>20.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Scacchi</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Cavagnini</surname>
              <given-names>F</given-names>
            </name>
          </person-group>
          <article-title>Acromegaly</article-title>
          <source>Pituitary</source>
          <year>2006</year>
          <volume>9</volume>
          <issue>4</issue>
          <fpage>297</fpage>
          <lpage>303</lpage>
          <pub-id pub-id-type="doi">10.1007/s11102-006-0409-4</pub-id>
          <pub-id pub-id-type="pmid">17077948</pub-id>
        </element-citation>
      </ref>
      <ref id="CR21">
        <label>21.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Ribeiro-Oliveira</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Barkan</surname>
              <given-names>A</given-names>
            </name>
          </person-group>
          <article-title>The changing face of acromegaly&#x2014;advances in diagnosis and treatment</article-title>
          <source>Nat Rev Endocrinol</source>
          <year>2012</year>
          <volume>8</volume>
          <issue>10</issue>
          <fpage>605</fpage>
          <lpage>611</lpage>
          <pub-id pub-id-type="doi">10.1038/nrendo.2012.101</pub-id>
          <pub-id pub-id-type="pmid">22733271</pub-id>
        </element-citation>
      </ref>
      <ref id="CR22">
        <label>22.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Sanno</surname>
              <given-names>N</given-names>
            </name>
            <name>
              <surname>Teramoto</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Osamura</surname>
              <given-names>RY</given-names>
            </name>
            <name>
              <surname>Horvath</surname>
              <given-names>E</given-names>
            </name>
            <name>
              <surname>Kovacs</surname>
              <given-names>K</given-names>
            </name>
            <name>
              <surname>Lloyd</surname>
              <given-names>RV</given-names>
            </name>
            <name>
              <surname>Scheithauer</surname>
              <given-names>BW</given-names>
            </name>
          </person-group>
          <article-title>Pathology of pituitary tumors</article-title>
          <source>Neurosurg Clin N Am</source>
          <year>2003</year>
          <volume>14</volume>
          <issue>1</issue>
          <fpage>25</fpage>
          <lpage>39, vi</lpage>
          <pub-id pub-id-type="doi">10.1016/S1042-3680(02)00035-9</pub-id>
          <pub-id pub-id-type="pmid">12690977</pub-id>
        </element-citation>
      </ref>
      <ref id="CR23">
        <label>23.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Scheithauer</surname>
              <given-names>BW</given-names>
            </name>
            <name>
              <surname>Kurtkaya-Yapicier</surname>
              <given-names>O</given-names>
            </name>
            <name>
              <surname>Kovacs</surname>
              <given-names>KT</given-names>
            </name>
            <name>
              <surname>Young</surname>
              <given-names>WF</given-names>
            </name>
            <name>
              <surname>Lloyd</surname>
              <given-names>RV</given-names>
            </name>
          </person-group>
          <article-title>Pituitary carcinoma: a clinicopathological review</article-title>
          <source>Neurosurgery</source>
          <year>2005</year>
          <volume>56</volume>
          <issue>5</issue>
          <fpage>1066</fpage>
          <lpage>1074</lpage>
          <pub-id pub-id-type="pmid">15854256</pub-id>
        </element-citation>
      </ref>
      <ref id="CR24">
        <label>24.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Melmed</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Ezrin</surname>
              <given-names>C</given-names>
            </name>
            <name>
              <surname>Kovacs</surname>
              <given-names>K</given-names>
            </name>
            <name>
              <surname>Goodman</surname>
              <given-names>RS</given-names>
            </name>
            <name>
              <surname>Frohman</surname>
              <given-names>LA</given-names>
            </name>
          </person-group>
          <article-title>Acromegaly due to secretion of growth hormone by an ectopic pancreatic islet-cell tumor</article-title>
          <source>N Engl J Med</source>
          <year>1985</year>
          <volume>312</volume>
          <issue>1</issue>
          <fpage>9</fpage>
          <lpage>17</lpage>
          <pub-id pub-id-type="doi">10.1056/NEJM198501033120103</pub-id>
          <pub-id pub-id-type="pmid">2981107</pub-id>
        </element-citation>
      </ref>
      <ref id="CR25">
        <label>25.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Beuschlein</surname>
              <given-names>F</given-names>
            </name>
            <name>
              <surname>Strasburger</surname>
              <given-names>CJ</given-names>
            </name>
            <name>
              <surname>Siegerstetter</surname>
              <given-names>V</given-names>
            </name>
            <name>
              <surname>Moradpour</surname>
              <given-names>D</given-names>
            </name>
            <name>
              <surname>Lichter</surname>
              <given-names>P</given-names>
            </name>
            <name>
              <surname>Bidlingmaier</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Blum</surname>
              <given-names>HE</given-names>
            </name>
            <name>
              <surname>Reincke</surname>
              <given-names>M</given-names>
            </name>
          </person-group>
          <article-title>Acromegaly caused by secretion of growth hormone by a non-Hodgkin&#x2019;s lymphoma</article-title>
          <source>N Engl J Med</source>
          <year>2000</year>
          <volume>342</volume>
          <issue>25</issue>
          <fpage>1871</fpage>
          <lpage>1876</lpage>
          <pub-id pub-id-type="doi">10.1056/NEJM200006223422504</pub-id>
          <pub-id pub-id-type="pmid">10861322</pub-id>
        </element-citation>
      </ref>
      <ref id="CR26">
        <label>26.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Thorner</surname>
              <given-names>MO</given-names>
            </name>
            <name>
              <surname>Perryman</surname>
              <given-names>RL</given-names>
            </name>
            <name>
              <surname>Cronin</surname>
              <given-names>MJ</given-names>
            </name>
            <name>
              <surname>Rogol</surname>
              <given-names>AD</given-names>
            </name>
            <name>
              <surname>Draznin</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Johanson</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Vale</surname>
              <given-names>W</given-names>
            </name>
            <name>
              <surname>Horvath</surname>
              <given-names>E</given-names>
            </name>
            <name>
              <surname>Kovacs</surname>
              <given-names>K</given-names>
            </name>
          </person-group>
          <article-title>Somatotroph hyperplasia. Successful treatment of acromegaly by removal of a pancreatic islet tumor secreting a growth hormone-releasing factor</article-title>
          <source>J Clin Invest</source>
          <year>1982</year>
          <volume>70</volume>
          <issue>5</issue>
          <fpage>965</fpage>
          <lpage>977</lpage>
          <pub-id pub-id-type="doi">10.1172/JCI110708</pub-id>
          <pub-id pub-id-type="pmid">6290540</pub-id>
        </element-citation>
      </ref>
      <ref id="CR27">
        <label>27.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Fainstein Day</surname>
              <given-names>P</given-names>
            </name>
            <name>
              <surname>Frohman</surname>
              <given-names>L</given-names>
            </name>
            <name>
              <surname>Garcia Rivello</surname>
              <given-names>H</given-names>
            </name>
            <name>
              <surname>Reubi</surname>
              <given-names>JC</given-names>
            </name>
            <name>
              <surname>Sevlever</surname>
              <given-names>G</given-names>
            </name>
            <name>
              <surname>Glerean</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Fernandez Gianotti</surname>
              <given-names>T</given-names>
            </name>
            <name>
              <surname>Pietrani</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Rabadan</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Racioppi</surname>
              <given-names>S</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Ectopic growth hormone-releasing hormone secretion by a metastatic bronchial carcinoid tumor: a case with a non hypophysial intracranial tumor that shrank during long acting octreotide treatment</article-title>
          <source>Pituitary</source>
          <year>2007</year>
          <volume>10</volume>
          <issue>3</issue>
          <fpage>311</fpage>
          <lpage>319</lpage>
          <pub-id pub-id-type="doi">10.1007/s11102-007-0019-9</pub-id>
          <pub-id pub-id-type="pmid">17373589</pub-id>
        </element-citation>
      </ref>
      <ref id="CR28">
        <label>28.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Colao</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Pivonello</surname>
              <given-names>R</given-names>
            </name>
            <name>
              <surname>Marzullo</surname>
              <given-names>P</given-names>
            </name>
            <name>
              <surname>Auriemma</surname>
              <given-names>RS</given-names>
            </name>
            <name>
              <surname>De Martino</surname>
              <given-names>MC</given-names>
            </name>
            <name>
              <surname>Ferone</surname>
              <given-names>D</given-names>
            </name>
            <name>
              <surname>Lombardi</surname>
              <given-names>G</given-names>
            </name>
          </person-group>
          <article-title>Severe systemic complications of acromegaly</article-title>
          <source>J Endocrinol Invest</source>
          <year>2005</year>
          <volume>28</volume>
          <issue>5 Suppl</issue>
          <fpage>65</fpage>
          <lpage>77</lpage>
          <pub-id pub-id-type="pmid">16114280</pub-id>
        </element-citation>
      </ref>
      <ref id="CR29">
        <label>29.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Isgaard</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>Arcopinto</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Karason</surname>
              <given-names>K</given-names>
            </name>
            <name>
              <surname>Cittadini</surname>
              <given-names>A</given-names>
            </name>
          </person-group>
          <article-title>GH and the cardiovascular system: an update on a topic at heart</article-title>
          <source>Endocrine</source>
          <year>2015</year>
          <volume>48</volume>
          <issue>1</issue>
          <fpage>25</fpage>
          <lpage>35</lpage>
          <pub-id pub-id-type="doi">10.1007/s12020-014-0327-6</pub-id>
          <pub-id pub-id-type="pmid">24972804</pub-id>
        </element-citation>
      </ref>
      <ref id="CR30">
        <label>30.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Arosio</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Reimondo</surname>
              <given-names>G</given-names>
            </name>
            <name>
              <surname>Malchiodi</surname>
              <given-names>E</given-names>
            </name>
            <name>
              <surname>Berchialla</surname>
              <given-names>P</given-names>
            </name>
            <name>
              <surname>Borraccino</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>De Marinis</surname>
              <given-names>L</given-names>
            </name>
            <name>
              <surname>Pivonello</surname>
              <given-names>R</given-names>
            </name>
            <name>
              <surname>Grottoli</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Losa</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Cannav&#xF2;</surname>
              <given-names>S</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Predictors of morbidity and mortality in acromegaly: an Italian survey</article-title>
          <source>Eur J Endocrinol</source>
          <year>2012</year>
          <volume>167</volume>
          <issue>2</issue>
          <fpage>189</fpage>
          <lpage>198</lpage>
          <pub-id pub-id-type="pmid">22596288</pub-id>
        </element-citation>
      </ref>
      <ref id="CR31">
        <label>31.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Doga</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Bonadonna</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Burattin</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Giustina</surname>
              <given-names>A</given-names>
            </name>
          </person-group>
          <article-title>Ectopic secretion of growth hormone-releasing hormone (GHRH) in neuroendocrine tumors: relevant clinical aspects</article-title>
          <source>Ann Oncol</source>
          <year>2001</year>
          <volume>12</volume>
          <issue>Suppl 2</issue>
          <fpage>S89</fpage>
          <lpage>S94</lpage>
          <pub-id pub-id-type="doi">10.1093/annonc/12.suppl_2.S89</pub-id>
          <pub-id pub-id-type="pmid">11762359</pub-id>
        </element-citation>
      </ref>
      <ref id="CR32">
        <label>32.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Colak Ozbey</surname>
              <given-names>N</given-names>
            </name>
            <name>
              <surname>Kapran</surname>
              <given-names>Y</given-names>
            </name>
            <name>
              <surname>Bozbora</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Erbil</surname>
              <given-names>Y</given-names>
            </name>
            <name>
              <surname>Tascioglu</surname>
              <given-names>C</given-names>
            </name>
            <name>
              <surname>Asa</surname>
              <given-names>SL</given-names>
            </name>
          </person-group>
          <article-title>Ectopic growth hormone-releasing hormone secretion by a neuroendocrine tumor causing acromegaly: long-term follow-up results</article-title>
          <source>Endocr Pathol</source>
          <year>2009</year>
          <volume>20</volume>
          <issue>2</issue>
          <fpage>127</fpage>
          <lpage>132</lpage>
          <pub-id pub-id-type="doi">10.1007/s12022-009-9067-1</pub-id>
          <pub-id pub-id-type="pmid">19301154</pub-id>
        </element-citation>
      </ref>
      <ref id="CR33">
        <label>33.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Furrer</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>H&#xE4;ttenschwiler</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Komminoth</surname>
              <given-names>P</given-names>
            </name>
            <name>
              <surname>Pfammatter</surname>
              <given-names>T</given-names>
            </name>
            <name>
              <surname>Wiesli</surname>
              <given-names>P</given-names>
            </name>
          </person-group>
          <article-title>Carcinoid syndrome, acromegaly, and hypoglycemia due to an insulin-secreting neuroendocrine tumor of the liver</article-title>
          <source>J Clin Endocrinol Metab</source>
          <year>2001</year>
          <volume>86</volume>
          <issue>5</issue>
          <fpage>2227</fpage>
          <lpage>2230</lpage>
          <pub-id pub-id-type="doi">10.1210/jcem.86.5.7461</pub-id>
          <pub-id pub-id-type="pmid">11344231</pub-id>
        </element-citation>
      </ref>
      <ref id="CR34">
        <label>34.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Weiss</surname>
              <given-names>DE</given-names>
            </name>
            <name>
              <surname>Vogel</surname>
              <given-names>H</given-names>
            </name>
            <name>
              <surname>Lopes</surname>
              <given-names>MB</given-names>
            </name>
            <name>
              <surname>Chang</surname>
              <given-names>SD</given-names>
            </name>
            <name>
              <surname>Katznelson</surname>
              <given-names>L</given-names>
            </name>
          </person-group>
          <article-title>Ectopic acromegaly due to a pancreatic neuroendocrine tumor producing growth hormone-releasing hormone</article-title>
          <source>Endocr Pract</source>
          <year>2011</year>
          <volume>17</volume>
          <issue>1</issue>
          <fpage>79</fpage>
          <lpage>84</lpage>
          <pub-id pub-id-type="doi">10.4158/EP10165.CR</pub-id>
          <pub-id pub-id-type="pmid">20713338</pub-id>
        </element-citation>
      </ref>
      <ref id="CR35">
        <label>35.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Sala</surname>
              <given-names>E</given-names>
            </name>
            <name>
              <surname>Ferrante</surname>
              <given-names>E</given-names>
            </name>
            <name>
              <surname>Verrua</surname>
              <given-names>E</given-names>
            </name>
            <name>
              <surname>Malchiodi</surname>
              <given-names>E</given-names>
            </name>
            <name>
              <surname>Mantovani</surname>
              <given-names>G</given-names>
            </name>
            <name>
              <surname>Filopanti</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Ferrero</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Pietrabissa</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Vanoli</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>La Rosa</surname>
              <given-names>S</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Growth hormone-releasing hormone-producing pancreatic neuroendocrine tumor in a multiple endocrine neoplasia type 1 family with an uncommon phenotype</article-title>
          <source>Eur J Gastroenterol Hepatol</source>
          <year>2013</year>
          <volume>25</volume>
          <issue>7</issue>
          <fpage>858</fpage>
          <lpage>862</lpage>
          <pub-id pub-id-type="doi">10.1097/MEG.0b013e32835f433f</pub-id>
          <pub-id pub-id-type="pmid">23542451</pub-id>
        </element-citation>
      </ref>
      <ref id="CR36">
        <label>36.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Butler</surname>
              <given-names>PW</given-names>
            </name>
            <name>
              <surname>Cochran</surname>
              <given-names>CS</given-names>
            </name>
            <name>
              <surname>Merino</surname>
              <given-names>MJ</given-names>
            </name>
            <name>
              <surname>Nguyen</surname>
              <given-names>DM</given-names>
            </name>
            <name>
              <surname>Schrump</surname>
              <given-names>DS</given-names>
            </name>
            <name>
              <surname>Gorden</surname>
              <given-names>P</given-names>
            </name>
          </person-group>
          <article-title>Ectopic growth hormone-releasing hormone secretion by a bronchial carcinoid tumor: clinical experience following tumor resection and long-acting octreotide therapy</article-title>
          <source>Pituitary</source>
          <year>2012</year>
          <volume>15</volume>
          <issue>2</issue>
          <fpage>260</fpage>
          <lpage>265</lpage>
          <pub-id pub-id-type="doi">10.1007/s11102-010-0226-7</pub-id>
          <pub-id pub-id-type="pmid">20379782</pub-id>
        </element-citation>
      </ref>
      <ref id="CR37">
        <label>37.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Lock</surname>
              <given-names>KY</given-names>
            </name>
            <name>
              <surname>Lau</surname>
              <given-names>IT</given-names>
            </name>
            <name>
              <surname>Yeung</surname>
              <given-names>CK</given-names>
            </name>
            <name>
              <surname>Chan</surname>
              <given-names>CP</given-names>
            </name>
          </person-group>
          <article-title>An unusual cause of acromegaly</article-title>
          <source>Hong Kong Med J</source>
          <year>2014</year>
          <volume>20</volume>
          <issue>4</issue>
          <fpage>331</fpage>
          <lpage>334</lpage>
          <pub-id pub-id-type="doi">10.12809/hkmj134044</pub-id>
          <pub-id pub-id-type="pmid">25104005</pub-id>
        </element-citation>
      </ref>
    </ref-list>
  </back>
</article>
</pmc-articleset>
